Page 1877 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 108 Graft-Versus-Host Disease and Graft-Versus-Leukemia Responses 1668.e1

REFERENCES 25. Ferrara JL, Deeg HJ: Graft-versus-host disease. N Engl J Med 324:667,
1991.
1. Barnes D, Corp M, Loutit J, et al: Treatment of murine leukaemia with 26. Antin JH, Bierer BE, Smith BR, et al: Selective depletion of bone
x-rays and homologous bone marrow: preliminary communication. Br marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective
Med J 2:626, 1956. prophylaxis for graft-versus-host disease in patients with hematologic
2. Barnes D, Loutit J: Treatment of murine leukaemia with x-rays and malignancies. Blood 78:2139, 1991.
homologous bone marrow. Br J Haematol 3:241, 1957. 27. Nevo S, Enger C, Swan V, et al: Acute bleeding after allogeneic bone
3. Truitt R, Johnson B, McCabe C, et al: Graft versus leukemia. In Ferrara marrow transplantation: association with graft versus host disease and
J, Deeg H, Burakoff S, editors: Graft-vs-host disease, ed 2, New York, effect on survival. Transplantation 67:681, 1999.
1997, Marcel Dekker, Inc., p 385. 28. Iqbal N, Salzman D, Lazenby AJ, et al: Diagnosis of gastrointestinal
4. Billingham RE: The biology of graft-versus-host reactions. Harvey Lect graft-versus-host disease. Am J Gastroenterol 95:3034, 2000.
62:21, 1966-67. 29. Ponec RJ, Hackman RC, McDonald GB: Endoscopic and histologic
5. Petersdorf EW: Immunogenomics of unrelated hematopoietic cell diagnosis of intestinal graft-versus-host disease after marrow transplan-
transplantation. Curr Opin Immunol 18:559, 2006. tation. Gastrointest Endosc 49:612, 1999.
6. Erlich HA, Opelz G, Hansen J: HLA DNA typing and transplantation. 30. Snover DC: Mucosal damage simulating acute graft-versus-host reac-
Immunity 14:347, 2001. tion in cytomegalovirus colitis. Transplantation 39:669, 1985.
7. Shlomchik WD: Graft-versus-host disease. Nat Rev Immunol 7:340, 31. Levine JE, Huber E, Hammer ST, et al: Low Paneth cell numbers at
2007. onset of gastrointestinal graft-versus-host disease identify patients at
8. Mori M, Beatty PG, Graves M, et al: HLA gene and haplotype frequen- high risk for nonrelapse mortality. Blood 122(8):1505–1509, 2013.
cies in the North American population: the National Marrow Donor 32. Snover DC, Weisdorf SA, Ramsay NK, et al: Hepatic graft versus host
Program Donor Registry. Transplantation 64:1017, 1997. disease: a study of the predictive value of liver biopsy in diagnosis.
9. Goulmy E, Schipper R, Pool J, et al: Mismatches of minor histo- Hepatology 4:123, 1984.
compatibility antigens between HLA-identical donors and recipients 33. Cooke KR, Yanik G: Acute lung injury after allogeneic stem cell
and the development of graft-versus-host disease after bone marrow transplantation: is the lung a target of acute graft-versus-host disease?
transplantation. N Engl J Med 334:281, 1996. Bone Marrow Transplant 34:753, 2004.
10. Deeg HJ, Cottler-Fox M: Clinical spectrum and pathophysiology of 34. Fukuda T, Hackman RC, Guthrie KA, et al: Risks and outcomes of
acute graft-vs.-host disease. In Burakoff SJ, Deeg HJ, Ferrara J, et al, idiopathic pneumonia syndrome after nonmyeloablative and conven-
editors: Graft-vs.-host disease: immunology, pathophysiology, and treat- tional conditioning regimens for allogeneic hematopoietic stem cell
ment, New York, 1990, Marcel Dekker, Inc., p 539. transplantation. Blood 102:2777, 2003.
11. Arai S, Lee LA, Vogelsang GB: A systematic approach to hepatic com- 35. Lee CK, Gingrich RD, Hohl RJ, et al: Engraftment syndrome in
plications in hematopoietic stem cell transplantation. J Hematother Stem autologous bone marrow and peripheral stem cell transplantation. Bone
Cell Res 11:215, 2002. Marrow Transplant 16:175, 1995.
12. Arai S, Margolis J, Zahurak M, et al: Poor outcome in steroid-refractory 36. Gorak E, Geller N, Srinivasan R, et al: Engraftment syndrome after
graft-versus-host disease with antithymocyte globulin treatment. Biol nonmyeloablative allogeneic hematopoietic stem cell transplantation:
Blood Marrow Transplant 8:155, 2002. incidence and effects on survival. Biol Blood Marrow Transplant 11:542,
13. Sale GE, Shulman HM: The pathology of bone marrow transplantation, 2005.
New York, 1984, Masson. 37. Spitzer TR: Engraftment syndrome following hematopoietic stem cell
14. Sale GE: Does graft-versus-host disease attack epithelial stem cells? Mol transplantation. Bone Marrow Transplant 27:893, 2001.
Med Today 114, 1996. 38. Sviland L, Pearson AD, Eastham EJ, et al: Histological features of
15. Sale GE, Shulman HM, Gallucci BB, et al: Young rete ridge keratino- skin and rectal biopsy specimens after autologous and allogeneic bone
cytes are preferred targets in cutaneous graft-vs-host disease. Am J Pathol marrow transplantation. J Clin Pathol 41:148, 1988.
118:278, 1985. 39. van Bekkum DW, De Vries MJ: Radiation chimaeras, London, 1967,
16. Weisdorf DJ, Hurd D, Carter S, et al: Prospective grading of graft- Logos Press.
versus-host disease after unrelated donor marrow transplantation: 40. Korngold R, Sprent J: Purified T cell subsets and lethal graft-versus-host
a grading algorithm versus blinded expert panel review. Biol Blood disease in mice. In Gale RP, Champlin R, editors: Progress in bone
Marrow Transplant 9:512, 2003. marrow transplant, New York, 1987, Alan R. Liss, Inc., p 213.
17. Martin PJ, Nash RA: Pitfalls in the design of clinical trials for preven- 41. Kernan NA, Bartsch G, Ash RC, et al: Analysis of 462 transplanta-
tion or treatment of acute graft-versus-host disease. Biol Blood Marrow tions from unrelated donors facilitated by the National Marrow Donor
Transplant 12:31, 2006. Program. N Engl J Med 328:593, 1993.
18. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft- 42. Sun Y, Tawara I, Toubai T, et al: Pathophysiology of acute graft-versus-
versus-host disease in human recipients of marrow from HL-A-matched host disease: recent advances. Transl Res 150:197, 2007.
sibling donors. Transplantation 18:295, 1974. 43. Aosai F, Ohlen C, Ljunggren HG, et al: Different types of allospecific
19. Leisenring WM, Martin PJ, Petersdorf EW, et al: An acute graft-versus- CTL clones identified by their ability to recognize peptide loading-
host disease activity index to predict survival after hematopoietic cell defective target cells. Eur J Immunol 21:2767, 1991.
transplantation with myeloablative conditioning regimens. Blood 44. Wang W, Man S, Gulden PH, et al: Class I-restricted alloreactive
108:749, 2006. cytotoxic T lymphocytes recognize a complex array of specific MHC-
20. Anasetti C, Beatty PG, Storb R, et al: Effect of HLA incompatibility on associated peptides. J Immunol 160:1091, 1998.
graft-versus-host disease, relapse, and survival after marrow transplanta- 45. Man S, Salter RD, Engelhard VH: Role of endogenous peptide in
tion for patients with leukemia or lymphoma. Hum Immunol 29:79, human alloreactive cytotoxic T cell responses. Int Immunol 4:367, 1992.
1990. 46. Petersdorf EW, Malkki M: Genetics of risk factors for graft-versus-host
21. Deeg HJ, Antin JH: The clinical spectrum of acute graft-versus-host disease. Semin Hematol 43:11, 2006.
disease. Semin Hematol 43:24, 2006. 47. Barker JN, Wagner JE: Umbilical-cord blood transplantation for the
22. Antin JH, Ferrara JL: Cytokine dysregulation and acute graft-versus- treatment of cancer. Nat Rev Cancer 3:526, 2003.
host disease. Blood 80:2964, 1992. 48. Laughlin MJ, Eapen M, Rubinstein P, et al: Outcomes after transplan-
23. Goker H, Haznedaroglu IC, Chao NJ: Acute graft-vs-host disease: tation of cord blood or bone marrow from unrelated donors in adults
pathobiology and management. Exp Hematol 29:259, 2001. with leukemia. N Engl J Med 351:2265, 2004.
24. Vogelsang GB, Lee L, Bensen-Kennedy DM: Pathogenesis and treat- 49. Barker JN, Weisdorf DJ, DeFor TE, et al: Transplantation of two par-
ment of graft-versus-host disease after bone marrow transplant. Annu tially HLA-matched umbilical cord blood units to enhance engraftment
Rev Med 54:29, 2003. in adults with hematologic malignancy. Blood 105:1343, 2005.